Failure Mode and Effect Analysis (FMEA) for a DMLC Tracking System

Similar documents
SnapShot IMRT with compensators and FFF beams

CLINICAL IMPLEMENTATION OF RAPIDARC Treatment Planning Strategies to Improve Dose Distributions

CHAPTER 4 PRE TREATMENT PATIENT SPECIFIC QUALITY ASSURANCE OF RAPIDARC PLANS

Quality Management Determined from Risk Assessment

Commissioning an IMRT System for MLC Delivery. Gary A. Ezzell., Ph.D. Mayo Clinic Scottsdale

DATA ITEM DESCRIPTION Title: Failure Modes, Effects, and Criticality Analysis Report

IMRT in clinical practice at the UMC-Utrecht. Utrecht

Commissioning and quality assurance of a commercial intensity modulated radiotherapy (IMRT) treatment planning system PrecisePLAN

Risk Assessment Guidance for QM in Brachytherapy. Conflicts. Learning Objectives. Example Procedure

Clinical Implementation of Volumetric Modulated Arc Therapy

Treatment plan complexity metrics for predicting IMRT pretreatment. assurance results. Scott Crowe, QUT

Basics of Proton Therapy. Proton Treatment Planning and Beam Optimization

ANZAI AZ-733VI. Respiratory Gating System. since 1976

Using what we have. Sherman Eagles SoftwareCPR.

Comparison of ionization chambers of various volumes for IMRT absolute dose verification

How to Define Your Systems and Assets to Support Reliability. How to Define Your Failure Reporting Codes to Support Reliability

Real-Time & Embedded Systems

Introduction. Introduction. The CyberKnife SRS/SBRT System. Introduction. Contour Structures. CyberKnife Components

Exercise Quality Management

Safety Critical Systems

PTCOG Safety Group Report on Aspects of Safety in Particle Therapy Version 2

Reliability engineering is the study of the causes, distribution and prediction of failure.

DETERMINATION OF SAFETY REQUIREMENTS FOR SAFETY- RELATED PROTECTION AND CONTROL SYSTEMS - IEC 61508

TG219: IT'S USE, STRENGTHS AND WEAKNESSES

Electronic Oncology Systems the Management and the Safety Measures. Hansen Chen, Director, TDSI

TG-119 IMRT Commissioning Tests Instructions for Planning, Measurement, and Analysis Version 10/21/2009

RESPIRATORY MOTION IN RADIATION THERAPY

Determining Occurrence in FMEA Using Hazard Function

Astral in AirView: Improving patient care through connectivity. ResMed.com

Monitor Unit Calculations Part 1. Return to our first patient. Purpose. 62 yr old woman with Stage IIIB (T1N3M0) NSCLC rt lower lobe Dose prescription

Automatic treatment planning an MCO perspective

10 Best Practices for Electrosurgical Unit Testing

Astral in AirView: Improving patient care through connectivity. ResMed.com

User Manual 1 P a g e Rev. V1.6-EN 11/08/2014

Implementation of respiratory-gated VMAT on a Versa HD linear accelerator

FMEA- FA I L U R E M O D E & E F F E C T A N A LY S I S. PRESENTED BY: AJITH FRANCIS

Failure Modes And Effects Analysis Fmea Tool

Notes on Risk Analysis

VMAT linear accelerator commissioning and quality assurance: dose control and gantry speed tests

Commissioning and quality assurance for a respiratory training system based on audiovisual biofeedback

How to Design Medical Accelerator Systems for Reliability: IBA PT System

Understanding safety life cycles

Well-formed Dependency and Open-loop Safety. Based on Slides by Professor Lui Sha

Commissioning of Elekta 6MV FFF Versa HD and Pinnacle

Critical Systems Validation

Only 8% to go. TOTAL 1494 of 1623 ACTIVE INSTITUTIONS (92%) May-09. May-04 Nov-04. May-07. Nov-02 May-03. Nov-05. Nov-06. Nov-07 May-08.

3. Real-time operation and review of complex circuits, allowing the weighing of alternative design actions.

FMEA What s the Worst That Could Happen?

Violation Risk Factor and Violation Severity Level Assignments Project Generator Verification

Physicist's Responsibility On End-Of-Life for Brachytherapy Devices and Software

Relative Dosimetry. Photons

Functional safety. Functional safety of Programmable systems, devices & components: Requirements from global & national standards

V8600 Ventilator. Integrated Invasive & Noninvasive Ventilation

Federal Aviation Administration Safety & Human Factors Analysis of a Wake Vortex Mitigation Display System

ANALYSIS OF OFF-AXIS ENHANCDED DYNAMIC WEDGE DOSIMETRY USING A 2D DIODE ARRAY A CREATIVE PROJECT (3 SEMESTER HOURS) SUBMITTED TO THE GRADUATE SCHOOL

Exposure System Selection

PROCEDURE. April 20, TOP dated 11/1/88

Traditional Approaches to Risk Management and Medical Device Software. Are They Good Enough? Can We Do Better?

Outcomes of an Innovative Outpatient Monitor Service for Gynaecological Patients The Case Study of the Royal Free Hospital

Risk Management File (short example) Cybathlon Fan. Created by. Responsibility and Approval. Version 1.0

Review of fundamental photon dosimetry quantities

Failure Modes Events Analysis. Dr Tai Hwei Yee DCQO, National Healthcare Group ACMB ( Clinical Quality & Audit), TTSH

Safety-Critical Systems

Pneumatic QEV. SIL Safety Manual SIL SM Compiled By : G. Elliott, Date: 8/19/2015. Innovative and Reliable Valve & Pump Solutions

Safety Manual VEGAVIB series 60

Innovation at its best

FP15 Interface Valve. SIL Safety Manual. SIL SM.018 Rev 1. Compiled By : G. Elliott, Date: 30/10/2017. Innovative and Reliable Valve & Pump Solutions

SIL Safety Manual. ULTRAMAT 6 Gas Analyzer for the Determination of IR-Absorbing Gases. Supplement to instruction manual ULTRAMAT 6 and OXYMAT 6

Bespoke Hydraulic Manifold Assembly

Understanding the How, Why, and What of a Safety Integrity Level (SIL)

SPR - Pneumatic Spool Valve

Marine Risk Assessment

Questions & Answers About the Operate within Operate within IROLs Standard

Solenoid Valves For Gas Service FP02G & FP05G

Tissue-Tek Prisma Plus & Tissue-Tek Glas TM g2

Module No. # 04 Lecture No. # 3.1 Case studies (continued) (Refer Slide Time: 00:10)

Hazard analysis. István Majzik Budapest University of Technology and Economics Dept. of Measurement and Information Systems

Clinical Study Synopsis

Outline. Chapter 11 Treatment Planning Single Beams. Patient dose calculation. Patient dose calculation. Effect of the curved contour surface

New Generation System M, leading the World in the Non-Invasive Measurement of Critical Real-Time Parameters.

SOP Title Review of Research: Devices for Humanitarian Uses

Three Approaches to Safety Engineering. Civil Aviation Nuclear Power Defense

Clinical Implementation of the TG-51 Protocol. David Followill Radiological Physics Center Houston Texas

PSM I PROFESSIONAL SCRUM MASTER

Disclosures. What Is So Hard? End of ITV: Gating is the Best ITV Killer 8/3/2016. Daniel A. Low, Ph.D. UCLA. Varian Grant Siemens Grant Accuray Grant

Absorption measurements for a carbon fiber couch top and its modelling in a treatment planning system

PL estimation acc. to EN ISO

Slippage Detection and Traction Control System Reliability Report

Pile Gripper Systems

Every things under control High-Integrity Pressure Protection System (HIPPS)

Methods to model and predict the ViewRay treatment deliveries to aid patient scheduling and treatment planning

Phase B: Parameter Level Design

VALVE CRITICALITY MODELING

Gas Network Craftsperson

Supporting your patients every breath

Safety Manual. Process pressure transmitter IPT-1* 4 20 ma/hart. Process pressure transmitter IPT-1*

Spasticity / Dystonia

Why do I need dual channel safety? Pete Archer - Product Specialist June 2018

Employ The Risk Management Process During Mission Planning

Statistical determinations of the gating windows in the. respiratory gated radiotherapy using the visible

Transcription:

Failure Mode and Effect Analysis (FMEA) for a DMLC Tracking System Amit Sawant 1, Sonja Dieterich 1, Michelle Svatos 2 and Paul Keall 1 1 Stanford University, Stanford, CA 2 Varian Medical Systems, Palo Alto, CA

Developing Quality Assurance Guidelines for DMLC Tracking In order to translate DMLC tracking into the clinic, we need to develop and recommend reliable QA guidelines for tracking-based delivery Our goal is to maximize system diagnosis while minimizing the additional QA burden on the clinical staff Therefore, instead of recommending prescriptive QA procedures (i.e., test everything), we will develop a QA protocol based on a failure mode and effect analysis (FMEA) of a DMLC tracking system

What Is FMEA? FMEA is a quality management technique for risk assessment and safety improvement of complex processes The FMEA methodology charts a process identifies potential modes and causes of failure anticipates the downstream effect of each failure FMEA is the recommended framework for evaluating the needs of modern radiotherapy QA in the forthcoming AAPM TG100

How is FMEA Performed? Each functional step in a process is mapped and a process tree is created Failure modes are identified - a failure is defined as an instance where an expected system response (e.g., beam hold) does not occur Each failure is assigned a risk probability number (RPN) which is defined as RPN = O S D, where O = probability of occurrence of the failure S = Severity of effect D = Detectibility of the failure during operation of the process

DMLC Tracking Process Tree

Only the steps within the shaded large blue region are tracking-specific. All other steps are common to any motion-managed radiotherapy e.g., gating We are only interested in failure modes of these tracking-specific steps Failure of other steps (i.e., those not in our box) should be assessed and rectified via pre-established QA procedures. Example 1. Position monitoring (PM) system is not accurate: Identified and rectified during the PM system QA. Example 2. One or more MLC leaves out of tolerance but beam-hold is not asserted: Identified and rectified during standard MLC QA.

Scale for O, S, D Values Value Probability of Occurrence [O] Severity of Effect [S] Source: National Cancer Institute Common Terminology Criteria for Adverse Events v4.0 (2009) Detectability [D] (Probability of Failure to Detect) 1 Very unlikely (< 0.01%) No adverse event (AE) Very unlikely (i.e., always detected) (< 0.01%) 2 3 Low probability (0.02% 0.04%) 4 5 Some probability (0.05% 0.4%) 6 7 Moderate probability (0.5% 1%) 8 9 High probability (2% 5%) 10 Certain failure (> 5%) Grade 1 Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not Indicated Grade 2 Moderate; minimal, local or noninvasive intervention indicated; limiting age-appropriate instrumental activities of daily living (ADL) 1 Grade 3 Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care ADL 2 Grade 4 Life threatening consequences. Urgent intervention indicated. Grade 5 Patient death related to AE Low probability (0.2% 0.5%) Some probability (1% 2%) Moderate probability (5% 10%) High probability (15% 20%) Certain failure (impossible to detect) (> 20%) Activities of Daily Living (ADL) 1 Instrumental ADL: preparing meals, shopping for groceries or clothes, using the telephone, managing money, etc. 2 Self-care ADL: bathing, dressing and undressing, feeding self, using the toilet, taking medications, and not bedridden.

Example O, S, D Scoring (non-tracking) Process Failure Mode Causes of Failure Effect of Failure Probability of Occurrence [O] Severity of Effect [S] Detectability [D] Risk Prob Number RPN = O S D 1. Patient localization Patient moves > 50mm from planned position during beam on but motion is not detected Absence/failure of real-time position monitoring system Dose error >15% 5 8 8 320 2. Dose delivery Beam does not turn off after a field is delivered Multiple backup systems for beam-off fail Dose error >60% 2 10 1 20

FMEA for MLC Tracking The next two slides show a table for anticipated failure modes. Table 1 is for conventionally fractionated treatments. Table 2 is for hypofractionated treatments (e.g., SBRT) In each case, failure is quantified in terms of estimated dosimetric error. Dose error is defined as underdose to target and/or overdose to normal tissue Please enter your best estimates for O, S and D according to the scale that was provided in Slide#7

FMEA Conventional Fractionation Please enter your estimates of O, S and D Process Step Failure Mode Possible causes of Failure Effect of Failure (%Dose Error) O S D 1. Position Monitoring (PM) system estimates real-time target position 2. Tracking system receives realtime target position and recalculates MLC leaf positions as a function of dose fraction and target position Target moves outside spatial tolerance set by PM system, but beam hold is not asserted i. communication with PM system is lost, i.e., target position is no longer current but beam hold not asserted ii. error in coordinate system conversion iii. optimal leaf-fitting not achieved Beam hold not sent by monitoring system to tracking system i. PM system failure ii. data transfer cable(s) physically disconnected i. system installation error ii. hardware / software >15% >30% >60% changes Complex motion + highly modulated field > 10% 3. Tracking system checks if fluence map is completely within field 4. MLC controller actuates leaf motion. If leaves are within tolerance, linac delivers dose, else beam is held off. Other Beam hold not asserted when fluence map is partially or completely under one or more jaws i. system latency outside expected range ii. too many beam holds. Efficiency drops below desired threshold i. Software crash or failure ii. jaws outside tolerance i. hardware and/or software changes ii. changes in network connection speed MLC leaves cannot keep up with target motion > 20% > 5% Efficiency < 70%

FMEA Hypofractionation Please enter your estimates of O, S and D Process Step Failure Mode Possible causes of Failure Effect of Failure (%Dose Error) O S D 1. Position Monitoring (PM) system estimates real-time target position 2. Tracking system receives realtime target position and recalculates MLC leaf positions as a function of dose fraction and target position Target moves outside spatial tolerance set by PM system, but beam hold is not asserted i. communication with PM system is lost, i.e., target position is no longer current but beam hold not asserted ii. error in coordinate system conversion iii. optimal leaf-fitting not achieved Beam hold not sent by monitoring system to tracking system i. PM system failure ii. data transfer cable(s) physically disconnected i. system installation error ii. hardware / software >15% >30% >60% changes Complex motion + highly modulated field > 10% 3. Tracking system checks if fluence map is completely within field 4. MLC controller actuates leaf motion. If leaves are within tolerance, linac delivers dose, else beam is held off. Other Beam hold not asserted when fluence map is partially or completely under one or more jaws i. system latency outside expected range ii. too many beam holds. Efficiency drops below desired threshold i. Software crash or failure ii. jaws outside tolerance i. hardware and/or software changes ii. changes in network connection speed MLC leaves cannot keep up with target motion > 20% > 5% Efficiency < 70%

Thank You!